Merck KGaA — operating as MilliporeSigma in the U.S. and Canada — is a global CDMO and biopharmaceutical services provider headquartered in Germany. The company delivers integrated development, manufacturing, and testing solutions for small molecules, APIs, HPAPIs, PEGs, and novel conjugates. Through its BioReliance portfolio, MilliporeSigma offers GMP and GLP testing, biologics safety assessment, and product characterization. Its services span preclinical, clinical, and commercial stages, supporting drug development acceleration, targeted protein degradation, and advanced therapeutic modalities. Merck KGaA has decades of proven expertise in global contract development, manufacturing, and biosafety testing.
